NCT00002798 arm group 57f9bf49b997196de24ed1ead444d5d6 [clinicaltrials_resource:NCT00002798/arm-group/57f9bf49b997196de24ed1ead444d5d6]
etoposide [clinicaltrials_resource:207629ea010bdde85fc49b95787257b2]idarubicin [clinicaltrials_resource:3060ad35f73242d49f57324de87f196c]cytarabine [clinicaltrials_resource:4e1f2e8ab3b2bee562f0e4aad9e9025a]daunorubicin hydrochloride [clinicaltrials_resource:75ffe868ec617dce295d087ef1f9834d]thioguanine [clinicaltrials_resource:91beb8d25beebded63f85ba5e8069296]filgrastim [clinicaltrials_resource:9c47b8cba693e48be737016964ba9fd0]dexamethasone [clinicaltrials_resource:a29e549e0b1cf2ee8f26ab3081f162b6]Combination Chemotherapy With or Without Bone Marrow Transplantation in Treating Children With Acute Myelogenous Leukemia or Myelodysplastic Syndrome [clinicaltrials:NCT00002798]
arm group [clinicaltrials_vocabulary:arm-group]
NCT00002798 arm group 57f9bf49b997196de24ed1ead444d5d6 [clinicaltrials_resource:NCT00002798/arm-group/57f9bf49b997196de24ed1ead444d5d6]
Bio2RDF identifier
NCT00002798/arm-group/57f9bf49b997196de24ed1ead444d5d6
Bio2RDF namespace
clinicaltrials_resource
Bio2RDF uri
http://bio2rdf.org/clinicaltri ...... f9bf49b997196de24ed1ead444d5d6
description [clinicaltrials_vocabulary:description]
No further treatment
identifier
clinicaltrials_resource:NCT00002798/arm-group/57f9bf49b997196de24ed1ead444d5d6
title
NCT00002798 arm group 57f9bf49b997196de24ed1ead444d5d6
@en
type
label
NCT00002798 arm group 57f9bf49 ...... 9bf49b997196de24ed1ead444d5d6]
@en